期刊文献+

风湿寒症型类风湿性关节炎动物模型滑膜CD3、CD21和CD68的表达 被引量:2

The expression of CD3,CD21,CD68 in synovial membrane of rheumatic cold symptoms type of RA rat models
下载PDF
导出
摘要 ①目的探讨风湿寒症型大鼠类风湿性关节炎(RA)模型滑膜区域主要免疫细胞CD3、CD21、CD68的表达。②方法免疫组织化学方法检测风湿寒症型RA模型组(模型组)和对照组大鼠关节滑膜区域CD3、CD21和CD68的表达,分析该区域的主要免疫细胞成分。③结果模型组在造模后第21、28、35、42天CD3平均表达率呈逐渐上升趋势,第42天最高;且各时间点均高于对照组,差异均有统计学意义(P<0.05);模型组与对照组CD21在各时间点相比差异均无统计学意义(P>0.05);模型组CD68在造模后第28天和35天的表达率高于对照组,差异均具有统计学意义(P<0.05)。④结论风湿寒症型RA动物模型滑膜区域炎细胞浸润有T淋巴细胞和巨噬细胞,而其中T淋巴细胞是主要免疫细胞,B淋巴细胞与RA局部滑膜组织的损伤无关。 Objective To discuss the expression of the major immune cells in synovial membrane of rheumatic cold symptoms type of RA rat models.Methods IHC was performed to detect the expres-sion of synovial membrane of CD3,CD21,CD68 in RA model group and normal group.Analyzed the main immune cell components in the regional of synovial membrane.Results The average expression rate of CD3 antibody in model group was gradually increasing in the 21th,28th,35th and 42th day af-ter modeling,and the highest was the 42th day.Compared with the normal group,the model group had significant difference at the 21th,28th,35th and 42th day after modeling(P 〈0.05);Compared with the normal group,the average expression rate of CD2 1 in model group had no significant difference at the four stages(P〉0.05),the expression of CD68 in model group at the 28th and 35th day were high-er than the normal group,the difference was significant(P 〈0.05).Conclusion The inflammatory cells in the synovial membrane of RA has T lymphocytes and macrophages,and B lymphocytes are not related to the local synovial tissue of RA,but T lymphocytes are the main immune cells of RA.
机构地区 华北理工大学
出处 《华北理工大学学报(医学版)》 2016年第4期259-263,共5页 Journal of North China University of Science and Technology:Health Sciences Edition
关键词 类风湿性关节炎 滑膜CD3 CD21 CD68 Rheumatoid arthritis Synovial membrane
  • 相关文献

参考文献12

  • 1温博,曾升平.类风湿关节炎的研究进展[J].世界中西医结合杂志,2014,9(9):1014-1016. 被引量:77
  • 2Fabien Dfipis, Eric Hatterer, Cfiline Lamacchia, et al.Long-term amelioration of established col- lagen-induced arthritis achieved with short- term therapy combining anti-CD3 and anti- tumor necrosis factor treatments[J]. Arthritis & Rheumatism, 2012,64 (10) : 3189-3198. 被引量:1
  • 3Shawn D. P. Ellis,Jenny L. McGovern, Andrfi Maurik, et al. Induced CD8 + FoxP3 -t- Treg Cells in Rheumatoid Arthritis Are Modulated by p38 Phosphorylation and Monocytes Ex- pressing Membrane Tumor Necrosis Factora and CD86 [J]. Arthritis & Rheumatology, 2014, 66(10): 2694-2705. 被引量:1
  • 4Brown Chrysothemis, Esterhazy Daria, Sarde Aurelien, et al.Role of retinoic acid in the sta- bility of the T-helper-type 1 lineage and impli- cations for autoimmunity[J]. Lancet, 2015,385 (2) ,25-26. 被引量:1
  • 5Gerald T. NePom the role of the DR4 shared epitope in selection and autoreactive T cells in rheumatoid arthritis [J 1. Rheumatic Disease Clinics of North Ameriea,2001,27(2) .305-313. 被引量:1
  • 6Kimmig S, Baumgrass R. Biological switches. the'all-or-none" principle in T-cell activation[J]. Rheumatol, 2009,7 (9) : 560-565. 被引量:1
  • 7Renata I. Mazzucchelli,Agostino Riva, Scott K. Durum. The human IL-7 receptor gene: Dele- tions, polymorphisms and mutations[J]. Semi- nars in Immunology, 2012,24 (3) : 225-230. 被引量:1
  • 8杨金娜,刘晓光,李覃,陈虹,张予阳.Th17/Treg平衡在类风湿关节炎中作用的研究进展[J].中国药理学通报,2013,29(8):1045-1048. 被引量:45
  • 9Paulissen Sandra M J,Van Hamburg Jan Pier, Dankers Wendy, et al.The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis[J ]. Cytokine, 2015,74 (1) : 43-55. 被引量:1
  • 10Komatsu Noriko, Takayanagi Hiroshi. Regula- tory T cells in Arthritis[J].Progress in molec- ular biology and translational science, 2015,13 (6). 207-215. 被引量:1

二级参考文献34

  • 1沈佰华,王利,张继英,聂红,余奇文,陈广洁,程琳玲,柏峻,李宁丽,张冬青,冯国璋,戴号,夏青,胡冬仪,许荣,倪立清.类风湿关节炎患者外周血与病变部位自身反应性T细胞的免疫学特征[J].中华风湿病学杂志,2004,8(8):458-462. 被引量:5
  • 2蒋颖,赵岩,李荣滨,张卓莉,唐福林.重症/难治性结缔组织病患者自体外周血干细胞移植治疗前后TCRBV和CDR3的变化规律[J].基础医学与临床,2007,27(6):629-634. 被引量:1
  • 3Mitchell RA. Mechanisms and effectors of MIF-dependentpromotion of tumourigenesis. Cell Signal, 2004, 16 : 13 - 19. 被引量:1
  • 4Kudrin A, Scott M, Martin S, et al. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem, 2006, 281:29641 -29651. 被引量:1
  • 5Flaster H, Bemhagen J, Calandra T, et al. Overexpression of macrophage migration inhibitory factor glucocorticoid dyad : regulation of inflammation andimmunity. Mol Endocrinol, 2007, 21 1267 - 1280. 被引量:1
  • 6ho Y, Sasaki , Horimoto M, et al. Activation of mitogen- activated proteinkinases/extracellularsignal-regulated kinases in human hepatocellular carcinoma. Hepatology, 1998, 27:951 - 958. 被引量:1
  • 7Zou YQ, Lu LJ, Li S J, et al. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease. Clin Biochem, 2008, 41:519-524. 被引量:1
  • 8Yang Y, Degranpre P, Kharfi A, et al. Identification of macrophagemigration inhibitory factor as a potent endothelial cell growth promotingagent released by ectopic human endometrial ceils. J Clin Endocrinol Metab, 2000, 85:721 -727. 被引量:1
  • 9Del Vecchio MT, Tripodi SA, Arcuri F, et al. Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment related changes. Prostate, 2000, 45:51 -57. 被引量:1
  • 10Crowson CS,Matteson EL,Davis JM 3rd,et al.Contribution of obesity to the rise in incidence of rheumatoid arthritis[J].Arthritis Care Res (Hoboken),2013,65 (1):71-77. 被引量:1

共引文献127

同被引文献57

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部